Skip to main content
. 2025 Mar 18;26(6):2741. doi: 10.3390/ijms26062741
GLP-1 Glucagon-like peptide-1
GLP1R Glucagon-like peptide-1 receptor
GLP1RA Glucagon-like peptide-1 receptor agonist
MR Mendelian randomization
OR Odds ratio
CI Confidence interval
LD Linkage disequilibrium
RCT Randomized controlled trial
T2D Type 2 diabetes
ADHD Attention deficit hyperactivity disorder
AN Anorexia nervosa
ANX Anxiety
ASD Autism spectrum disorder
BD Bipolar disorder
MDD Major depressive disorder
PTSD Post-traumatic stress disorder
SZ Schizophrenia
CUD Cannabis use disorder
AUD Alcohol use disorder
IVW Inverse variance weighting
MR.RAPs Mendelian randomization robust adjusted profile scores